ALEC BRADBURY: Open Payments
NPI 1902557226 · SAN RAFAEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,911 in 26 payments from 9 companies in 2025. Trend: 2023 $7,072 · 2024 $5,946 · 2025 $4,911
Speaker / faculty: $3,430Food & beverage: $934Travel & lodging: $547
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 12 | $4,318 |
| ABBVIE INC. | 4 | $193 |
| Novo Nordisk Inc | 3 | $152 |
| Braeburn Inc. | 1 | $121 |
| Lilly USA, LLC | 2 | $43 |
| Exact Sciences Corporation | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Cranial Technologies, Inc | 1 | $17 |
| Amgen Inc. | 1 | $16 |
Products named: Epclusa, MAVYRET, BRIXADI, Wegovy, MOUNJARO, VRAYLAR, The Cologuard Plus Collection Kit, BEXSERO.
Industry payments across CA — which companies pay providers there.
